Company Filing History:
1 out of 410 
1 out of 32 
Years Active: 2024
Title: Innovations by Roberto Costante
Introduction
Roberto Costante is an accomplished inventor based in Pomezia, Italy. He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic agents for inflammatory diseases. His work has the potential to impact the treatment of various health conditions.
Latest Patents
Roberto Costante holds a patent for "Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases." This invention provides novel peptide inhibitors that target the interleukin-23 receptor. The related compositions and methods aim to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Roberto has worked with notable companies in the biotechnology sector. He has been associated with Janssen Biotech, Inc. and Protagonist Therapeutics, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development efforts.
Collaborations
Roberto has collaborated with esteemed colleagues, including Chengzao Sun and Brian Troy Frederick. These partnerships have fostered innovation and have been instrumental in advancing his research initiatives.
Conclusion
Roberto Costante's work exemplifies the spirit of innovation in the field of biomedical research. His contributions, particularly in developing peptide inhibitors for inflammatory diseases, highlight the importance of scientific advancements in improving health outcomes.